文献速递外周动脉疾病

长期使用类固醇对下肢外周动脉疾病动脉旁路术后伤口并发症的影响

Effect of Chronic Steroid Use on Postoperative Wound Complications in Patients Undergoing Arterial Bypass Surgery for Lower Extremity Peripheral Arterial Disease.
PubMed 文献 · Ann Vasc Surg · 2024-07-01

基于ACS-NSQIP 2005至2020年文件,共纳入44,675例因外周动脉疾病行主髂动脉或腹股沟下动脉旁路术的患者,其中1,807例长期使用类固醇,42,868例未长期使用。多因素logistic回归分析显示,长期使用类固醇与深部手术部位感染、任何手术部位感染及伤口裂开风险升高相关,并与脓毒症、肺炎、尿路感染、深静脉血栓、30天再入院、再手术及死亡率升高相关。

要点

  • 长期使用类固醇与深部手术部位感染(OR 1.37,95%CI 1.03-1.83)及任何手术部位感染(OR 1.22,95%CI 1.04-1.43)风险升高相关。
  • 长期使用类固醇与伤口裂开风险升高相关(OR 1.42,95%CI 1.03-1.96)。
  • 长期使用类固醇还与脓毒症、肺炎、尿路感染、深静脉血栓、30天再入院、再手术及死亡率升高相关。

核心结论

  • 本研究发现长期使用皮质类固醇与下肢动脉旁路术后手术部位感染风险升高相关。
  • 这类患者通常合并多种基础健康问题,强调需要个体化治疗和管理以减少类固醇相关术后并发症并改善生存。

研究设计与样本

  • 使用美国外科医师学会国家手术质量改进计划(ACS-NSQIP)2005至2020年文件,通过当前操作术语(CPT)代码识别所有因外周动脉疾病(PAD)接受主髂动脉或腹股沟下动脉旁路术的患者。
  • 共纳入44,675例接受开放下肢血运重建(LER)的患者,其中1,807例长期使用类固醇,42,868例未长期使用类固醇。
  • 采用χ2检验和独立t检验比较患者特征和30天结局,采用多因素logistic回归分析研究长期使用类固醇与伤口并发症的关联。

主要发现

  • 多因素logistic回归分析显示,长期使用类固醇与深部手术部位感染(SSIs)率升高相关(OR 1.37,95%CI 1.03-1.83)。
  • 长期使用类固醇与任何手术部位感染率升高相关(OR 1.22,95%CI 1.04-1.43)。
  • 长期使用类固醇与伤口裂开率升高相关(OR 1.42,95%CI 1.03-1.96)。
  • 长期使用类固醇者发生脓毒症(OR 1.56,95%CI 1.19-2.04)、肺炎(OR 1.44,95%CI 1.08-1.91)、尿路感染(UTI)(OR 1.54,95%CI 11.13-2.09)、深静脉血栓(DVT)(OR 1.60,95%CI 1.01-2.53)、30天再入院(OR 1.30,95%CI 1.12-1.50)、再手术(OR 1.17,95%CI 1.01-1.37)及死亡率(OR 1.33,95%CI 1.01-1.76)的比值比显著增加,与非长期使用类固醇者相比。

临床怎么用

  • 原文结论指出,长期使用皮质类固醇与下肢动脉旁路术后手术部位感染风险升高相关,这类患者通常合并多种基础健康问题,强调需要个体化治疗和管理以减少类固醇相关术后并发症并改善生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While existing literature reports adverse effects of chronic steroid use on surgical wound outcomes, there remains lack of data exploring the effect of steroids on postoperative outcomes following lower extremity arterial bypass surgery. This study aims to explore the effect of chronic steroid use on surgical outcomes in patients undergoing open revascularization for lower extremity arterial occlusive disease. METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) files between 2005 and 2020, all patients receiving aortoiliac or infrainguinal arterial bypass for peripheral arterial disease (PAD) were identified by Current Procedural Terminology (CPT) codes. Patient characteristics and 30-day outcomes were compared using χ2 test and independent t-test, and the association of chronic steroid use with wound complications was studied using multivariable logistic regression analysis. RESULTS: A total of 44,675 patients undergoing open lower extremity revascularization (LER) were identified, of which 1,807 patients were on chronic steroids, and 42,868 patients were not on chronic steroids. On multivariable logistic regression analysis, being on chronic steroids was associated with higher rates of deep surgical site infections (SSIs) (odds ratio [OR] 1.37, 95% confidence interval [CI] 1.03-1.83), any SSI (OR 1.22, 95% CI 1.04-1.43), and wound dehiscence (OR 1.42, 95% CI 1.03-1.96). Chronic steroid users also had significantly increased odds of developing sepsis (OR 1.56, 95% CI 1.19-2.04), pneumonia (OR 1.44, 95% CI 1.08-1.91), urinary tract infection (UTI) (OR 1.54, 95% CI 11.13-2.09), deep vein thrombosis (DVT) (OR 1.60, 95% CI 1.01-2.53), 30-day readmission (OR 1.30, 95% CI 1.12-1.50), reoperation (OR 1.17, 95% CI 1.01-1.37), and mortality (OR 1.33, 95% CI 1.01-1.76) compared with nonchronic steroid users. CONCLUSIONS: This study confirms that chronic corticosteroid use is associated with higher risk of SSIs in patients undergoing lower extremity arterial bypass surgery. These patients typically have various underlying health issues, emphasizing the need for personalized treatment and management to reduce steroid-related postoperative complications and improve survival.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chamseddine H, Sawma T, Slika H, et al. Effect of Chronic Steroid Use on Postoperative Wound Complications in Patients Undergoing Arterial Bypass Surgery for Lower Extremity Peripheral Arterial Disease. Ann Vasc Surg. 2024. PMID: 38960095. doi:10.1016/j.avsg.2024.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。